CPDA-1 140 mg/63mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 140 mg/63mL

CPDA-1 140 mg/63mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for medical use. Ideal for blood preservation and transfusion procedures.

Strength

140 mg/63mL

Pack Size

63 mL in 1 BAG (0942-6322-04)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 140 mg/63mL is primarily used to preserve blood components such as red blood cells and platelets. This solution helps maintain the viability and quality of blood during storage, making it suitable for transfusion purposes. It is commonly used in medical settings where blood preservation is required.

Side Effects

When used as directed, CPDA-1 140 mg/63mL helps to prevent blood clotting and maintains the integrity of blood components. It provides a stable environment for stored blood, ensuring it remains viable for transfusion. Common effects include the preservation of red blood cells and platelets.

Precautions & Warnings

CPDA-1 140 mg/63mL should be handled with care to avoid contamination. It is important to follow proper storage and administration guidelines to ensure the safety and efficacy of the solution. Always consult healthcare professionals for proper use and handling.

Avoid Interactions

CPDA-1 140 mg/63mL may interact with certain medications or substances. It is important to inform healthcare providers about any other medications or treatments being used. Avoid mixing with incompatible solutions to prevent adverse reactions.

Frequently Asked Questions

CPDA-1 140 mg/63mL is used to preserve blood components such as red blood cells and platelets for transfusion purposes.

CPDA-1 140 mg/63mL should be stored according to the manufacturer's guidelines to maintain its efficacy.

Common effects include the preservation of blood components and prevention of clotting during storage.

CPDA-1 140 mg/63mL should not be mixed with incompatible solutions to avoid adverse reactions.

CPDA-1 140 mg/63mL is manufactured by Fenwal, Inc. in the USA.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.